Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Dow
Merck
Teva
Accenture
McKesson
Medtronic
Fish and Richardson
Federal Trade Commission

Generated: December 10, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 39 16 291.5

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Shire Orphan TherapFIRAZYRicatibant acetateINJECTABLE;SUBCUTANEOUS022150-001Aug 25, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYTREATMENT OF PATHOLOGICAL STATE BY ANTAGONIZING BRADYKININ RECEPTOR INCLUDING TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist